出品/用户说“跨界医美或搅巨浪”跨界医美赛道迎来新“狠角”?近期, 农夫山泉 创始人钟睒睒通过其旗下养生堂、杭州久视,共计斥资34亿元入股山西 锦波生物 医药股份有限公司。交易完成后,钟睒睒间接控制锦波生物10.58%股份,一跃成为第二大股东。养生堂与锦波生物的合作,被不少业内人士视为医美跨界领域的又一大看点。实际上,用户数说进一步梳理发现,年初至今已有众多企业跨界入局/加码医美,如香港上市药...
Source Link出品/用户说“跨界医美或搅巨浪”跨界医美赛道迎来新“狠角”?近期, 农夫山泉 创始人钟睒睒通过其旗下养生堂、杭州久视,共计斥资34亿元入股山西 锦波生物 医药股份有限公司。交易完成后,钟睒睒间接控制锦波生物10.58%股份,一跃成为第二大股东。养生堂与锦波生物的合作,被不少业内人士视为医美跨界领域的又一大看点。实际上,用户数说进一步梳理发现,年初至今已有众多企业跨界入局/加码医美,如香港上市药...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.